The period also saw an eight-fold increase in the number of applications for new substances with a therapeutic effect on cardiovascular diseases, the department said.
In addition, as Rospatent clarified, the number of applications for antibacterial drugs, including broad-spectrum drugs and those aimed at treating tuberculosis, has tripled since February.
According to experts, inventors from universities are the most active in the field of pharmaceuticals in 2022 — they have filed 37% of the total number of applications in the field under consideration this year.
Pharmaceutical manufacturers are also active — they submitted 20% of applications.
Earlier it became known that in Russia the demand for dietary supplements and vitamins grew by almost 50% in the first quarter of 2022.